Shopping Cart
- Remove All
- Your shopping cart is currently empty
Melogliptin, also known as EMD-675992 and GRC-8200, is a potent and selective a dipeptidyl peptidase IV (DPP-IV) inhibitor potentially for treatment of type II diabetes. Melogliptin significantly reduced HbA1c from baseline as compared to placebo with a mean average reduction of 0.75 percent in patients receiving 50mg twice daily dose and 0.60 percent in patients receiving 100 mg once daily dose.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.729 € | 8-10 weeks | |
50 mg | 2.261 € | 8-10 weeks | |
100 mg | 2.945 € | 8-10 weeks |
Description | Melogliptin, also known as EMD-675992 and GRC-8200, is a potent and selective a dipeptidyl peptidase IV (DPP-IV) inhibitor potentially for treatment of type II diabetes. Melogliptin significantly reduced HbA1c from baseline as compared to placebo with a mean average reduction of 0.75 percent in patients receiving 50mg twice daily dose and 0.60 percent in patients receiving 100 mg once daily dose. |
Molecular Weight | 320.37 |
Formula | C15H21FN6O |
Cas No. | 868771-57-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.